KRAIG BIOCRAFT LABORATORIES, INC. Proceeds from Sale and Maturity of Held-to-maturity Securities
KRAIG BIOCRAFT LABORATORIES, INC. (KBLB) reported Proceeds from Sale and Maturity of Held-to-maturity Securities of $2.59 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities · last filed 2025-03-28
- KRAIG BIOCRAFT LABORATORIES, INC. proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2023-12-31 was $0.00.
- KRAIG BIOCRAFT LABORATORIES, INC. proceeds from sale and maturity of held-to-maturity securities for the quarter ending 2023-09-30 was $1.73M.
- KRAIG BIOCRAFT LABORATORIES, INC. proceeds from sale and maturity of held-to-maturity securities for fiscal 2023 was $2.59M.
| Period end | Proceeds from Sale and Maturity of Held-to-maturity Securities 3 month | Proceeds from Sale and Maturity of Held-to-maturity Securities 6 month | Proceeds from Sale and Maturity of Held-to-maturity Securities 9 month | Proceeds from Sale and Maturity of Held-to-maturity Securities 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $1.73M derived: sum of 2 quarters · filed 2025-03-28 | $2.59M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $1.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $2.59M 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $860.00K 10-Q · filed 2024-08-14 |